Metformin C4 Health

Metformin, the active ingredient in Metformin C4 Health, is a biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose levels and is indicated for adults with type 2 diabetes mellitus. The formulation provides consistent bioavailability and is taken under medical supervision.

GNH USA supplies Metformin C4 Health as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and efficient logistics for timely, across global distribution.

Metformin is a biguanide oral antidiabetic that improves glycemic control in patients with type 2 diabetes mellitus.

- Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.

Metformin may cause a range of adverse reactions, from mild gastrointestinal discomfort to rare but serious metabolic disturbances.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient metallic sensation in the mouth. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening accumulation of lactate. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: abnormal liver enzymes. - Vitamin B12 deficiency: may develop with long‑term use. - Hypoglycemia: uncommon when used alone but possible with other antidiabetics.

Metformin requires careful monitoring in specific clinical situations to minimise risk. - Renal function assessment: evaluate eGFR before initiation and periodically. - Hepatic impairment: avoid in patients with significant liver disease. - Risk of lactic acidosis: contraindicated in severe renal or cardiac failure. - Vitamin B12 monitoring: consider periodic testing during long‑term therapy. - Pregnancy and lactation: use only if clearly needed and prescribed by a physician. - Store at below 25°C: keep in the original container, protect from moisture and light.

Metformin can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis. - Diuretics (loop or thiazide): may impair renal function and raise metformin levels. - Other antidiabetic agents: increase risk of hypoglycemia when combined.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors/ARBs: monitor renal function and potassium. - Warfarin: occasional alteration of INR values. - Digoxin: monitor for toxicity. - Oral contraceptives: may affect glucose metabolism.